Importantly, we compared the performance of our HCC screening model with AFP in distinguishing HCC patients who were AFP-normal and early-stage HCC patients (Barcelona Clinic Liver Cancer [BCLC] stage 0-A) from the high-risk population. Here, AFP is linked to hepatocellular carcinoma.